Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$34.71 USD
-0.38 (-1.08%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $34.71 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
Biohaven Ltd. [BHVN]
Reports for Purchase
Showing records 161 - 180 ( 271 total )
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Troriluzole Disappoints in Alzheimer?s Disease Study; Reiterate Buy, Lower Price Target to $111
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Troriluzole Begins Phase 3 Program in OCD With Enrollment of First Patient; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 12/11/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Proprietary Survey Points to Migraine Leadership; Initiate With Buy and a $121 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker -- Week Ending 11/20/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 11/13/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Nurtec ODT Pushing Forward Ahead of Troriluzole Alzheimer''s Data
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker -- Week Ending
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Neurology Prescription Sales Tracker - Week Ending 10/23/20
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L